Charys Papagregoriou, PhD
Postdoctoral Research Fellow | MSCA Seal of Excellence Awardee
Academic qualifications
- PhD in Cancer Immunology & Immunotherapy, University of Southampton, School of Medicine, United Kingdom (2021)
- MSc in Cancer Immunology and Biotechnology (Distinction), University of Nottingham, School of Medicine, United Kingdom (2017)
- BSc (Hons) Biology, University of Nottingham, Life Sciences, United Kingdom (2016)
- MD Candidate (University of Nicosia, Cyprus)
Research interests and expertise
Her research focuses on translational cancer immunology and the development of adoptive cellular immunotherapies for both solid and haematological malignancies. Her expertise includes chimeric antigen receptor (CAR) T-cell therapy, tumour immunology, immune checkpoint modulation, multiparameter flow cytometry and preclinical mouse models of cancer.
She is particularly interested in developing novel cellular therapies and combination immunotherapy strategies to overcome the immunosuppressive tumour microenvironment and improve treatment outcomes for patients with cancer.
Her research has also received recognition through the European Commission's Marie Skłodowska-Curie Actions (MSCA) Seal of Excellence, with subsequent funding through the Research and Innovation Foundation's Horizon Europe - 2nd Opportunity - MSCA programme.
